Evidence map›Paper›PMID 40382321›Full record

ArticleNature communications2025

Prolonged normothermic perfusion of the kidney prior to transplantation: a historically controlled, phase 1 cohort study.

Richard Dumbill, Simon Knight, James Hunter, John Fallon, Daniel Voyce, Jacob Barrett, Matt Ellen, Elizabeth Conroy, Ian Sd Roberts, Tim James and 6 more

Abstract readClinical Trial, Phase I
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Advancements inFrontiers in transplantation · 2026
    Review
  14. Review
  15. Time as a Therapeutic Ally: The Promise of Long-Term Solid Organ and Tissue Perfusion.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Richard DumbillNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. richard.dumbill@nds.ox.ac.uk.ORCID http://orcid.org/0000-0003-1907-4758
Simon KnightNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-4837-9446
James HunterNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
John FallonNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-8644-9380
Daniel VoyceOrganOx Ltd, Oxford, UK.
Jacob BarrettOrganOx Ltd, Oxford, UK.ORCID http://orcid.org/0009-0000-3946-816X
Matt EllenOrganOx Ltd, Oxford, UK.
Elizabeth ConroyOxford Clinical Trials Research Unit, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-4858-727X
Ian Sd RobertsDepartment of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Tim JamesBiochemistry Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.ORCID http://orcid.org/0000-0002-5382-9838
Gabrielle AllenBiochemistry Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Jennifer BrookBiochemistry Department, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.ORCID http://orcid.org/0000-0003-3594-8996
Annemarie WeissenbacherDepartment of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Medical University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-0582-1815
Rutger PloegNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-7801-665X
Constantin CoussiosOrganOx Ltd, Oxford, UK. constantin.coussios@eng.ox.ac.uk.ORCID http://orcid.org/0000-0001-8792-7818
Peter FriendNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-0841-9685

Funding

DH | NIHR | Invention for Innovation (i4i) NIHR200022
6 · The paper itself

Abstract

Kidney transplantation is the preferred treatment for end-stage renal disease and is limited by donor organ availability. Normothermic Machine Perfusion (NMP) might facilitate safe transplantation of marginal organs. NKP1 is a single centre, phase 1, 36-patient, three-stage cohort study investigating the safety and feasibility of up to 24 hours of renal NMP prior to transplantation. 30-day graft survival (primary endpoint) was 100%. Secondary objectives were assessment of the effect of NMP on post-transplant clinical outcomes and ischaemia-reperfusion injury, identification of predictive biomarkers, and characterisation of the performance of the preservation system. Clinical outcomes were comparable to a matched control cohort with 12-month estimated glomerular filtration rate (eGFR) 46.3 vs 49.5 mL/min/1.73m

Indexed as

KidneyKidney Failure, ChronicKidney TransplantationOrgan PreservationPerfusionAdultAgedBiomarkersCohort StudiesFemaleGlomerular Filtration RateGraft SurvivalHumansMaleMiddle AgedReperfusion InjuryBiomarkers

Identifiers

PMID40382321
PMCPMC12085653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.